Towards Healthcare Research & Consulting

Calcium Hydroxylapatite Fillers Market Forecast and Growth Trends

According to Payal Rabde, who specializes in periodontal tissue regeneration, bone grafting, alveolar bone regeneration, and guided bone regeneration, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the calcium hydroxylapatite fillers market. The global calcium hydroxylapatite fillers market size was estimated at USD 1.67 billion in 2025 and is predicted to increase from USD 1.8 billion in 2026 to approximately USD 3.55 billion by 2035, expanding at a CAGR of 7.82% from 2026 to 2035. Her analysis highlights the increasing adoption of stem cell-based regenerative therapies, digital dentistry integrated with regenerative treatments, advanced bone graft substitutes, biomaterials-based dental grafts and scaffolds, and stem cell-based regenerative therapies. The research also examines the competitive strategies of key industry participants, including BioPlus Co. Ltd., CGVBio Co., Ltd., Merz Aesthetics, AbbVie, Dermax Medical Technology, and Medyglobal, shaping the future by advancing stem cell-based dental regeneration, expanding tissue engineering and biomaterial innovation, supporting minimally invasive regenerative dental procedures, strengthening regenerative solutions for periodontal and bone repair, and driving AI-assisted treatment planning and precision regenerative care in the global calcium hydroxylapatite fillers market.

Last Updated : 20 July 2026 Category: Therapeutic Area Insight Code: 6826 Format: PDF / PPT / Excel
Revenue, 2025
USD 1.67 Billion
Forecast, 2035
USD 3.55 Billion
CAGR, 2026-2035
7.82%
Report Coverage
Global

The global calcium hydroxylapatite fillers market size was estimated at USD 1.67 billion in 2025 and is predicted to increase from USD 1.8 billion in 2026 to approximately USD 3.55 billion by 2035, expanding at a CAGR of 7.82% from 2026 to 2035. The growth in the geriatric population is increasing the demand for calcium hydroxylapatite fillers globally. Expanding beauty awareness, social media influence, male aesthetics, technological advancements, and new product launches are also enhancing the market growth.

Calcium Hydroxylapatite Fillers Market Size is USD 1.8 Billion in 2026.

Key Takeaways

  • Calcium hydroxylapatite fillers sector pushed the market to USD 1.8 billion by 2026.
  • Long-term projections show USD 3.55 billion valuation by 2035.
  • Growth is expected at a steady CAGR of 7.82% in between 2026 to 2035.
  • North America held the major revenue share of 35% in the global calcium hydroxylapatite fillers market in 2025.
  • Asia Pacific held 20% share of the market in 2025 and is expected to grow at the fastest CAGR of 9.0% during the forecast period.
  • By type of product, the injectable fillers segment held a dominant revenue share of 75% of the market in 2025.
  • By type of product, the calcium hydroxylapatite-based fillers sub-segment held 15% of market share in 2025 and is expected to grow at the fastest CAGR of 9.10% during the forecast period.
  • By end-use application type, the aesthetic fillers segment held a dominant revenue share of 80% of the market in 2025.
  • By end-use application type, the lip augmentation sub-segment held 30% of market share in 2025 and is expected to grow at the fastest CAGR of 9.30% during the forecast period.
  • By distribution channel type, the hospitals & clinics segment held a dominant position in the calcium hydroxylapatite fillers market with a share of 60% in 2025.
  • By distribution channel type, the online sales segment held 20% of the market share in 2025 and is expected to grow at the fastest CAGR of 10.0% during the forecast period.

What are the Calcium Hydroxylapatite Fillers?

The calcium hydroxylapatite fillers market is driven by growing demand for minimally invasive cosmetic procedures and a shift towards regenerative aesthetics. The calcium hydroxylapatite fillers refer to the biocompatible and injectable dermal fillers used for aesthetic and medical applications. Their immediate volumizing effect, collagen stimulation, and gradual absorption are increasing their use for facial contouring, hand rejuvenation, lip augmentation, orthopedic, and reconstructive applications.

Calcium Hydroxylapatite Fillers Transform Aesthetic Medicine with Long-Lasting Collagen Regeneration

Calcium hydroxylapatite (CaHA) fillers are injectable dermal fillers composed of microscopic calcium hydroxylapatite particles suspended in gel carrier, used to restore facial volume, smooth wrinkles, and stimulate natural collagen production for long-lasting aesthetic enhancements. The calcium hydroxylapatite fillers market is expanding due to the rising demand for minimally invasive cosmetic procedures, increasing awareness of facial rejuvenation, and growing preference for long-lasting injectable treatments. Technological advancements in filler formulations, precision injection techniques, and combination aesthetic therapies are improving treatment outcomes and patient satisfaction. The increasing influence of medical aesthetics, expanding dermatology and cosmetic clinics, and growing acceptance among younger and aging populations are creating significant growth opportunities. Future expansion is expected through personalized aesthetic treatment, regenerative medicine innovation, AI-assisted facial assessment, and continuous product development focused on enhanced safety, durability, and natural-long results.

AI Technological Shifts in the Calcium Hydroxylapatite Fillers Market

AI offers a wide range of applications in calcium hydroxylapatite fillers, where it helps in the analysis of patient history, driving treatment optimization. It also helps in providing safe filler quantities and decision support for the development of personalized and combination therapies. It also provides 3D facial scans, promoting the development of designs with customized injection plans and the prediction of optimal filler volume and placements.

What are the Trends & Future Outlook of the Calcium Hydroxylapatite Fillers Market?

Blooming Cosmetic Procedures

The growing geriatric population, skin awareness, and male aesthetics are increasing demand for calcium hydroxylapatite fillers, driving the demand for non-surgical cosmetic procedures, for wrinkle correction, jawline enhancement, volume loss correction, and chin enhancement.

Expanding Applications

The rise in the calcium hydroxylapatite fillers applications is increasing, which is promoting their adoption rates for jawline, hands, neck, and chin contouring, along with reconstructive and medical treatments, where their growing use for body contouring and off-label uses are also increasing their multi-purpose applications.

Technological Advancements

Growing technological innovations are driving the advancements in injection techniques as well as promoting the development of hybrid fillers, biodegradable, and next-gen formulations, to offer enhanced biostimulatory, safe, advanced, and longer-lasting products.

Executive Summary Table

Table Scope
Market Size in 2026 USD 1.8 Billion
Projected Market Size in 2035 USD 3.55 Billion
CAGR (2026 - 2035) 7.82%
Leading Region North America by 35%
Key Applications Facial volumization, wrinkle correction, jawline enhancement, chin augmentation, hand rejuvenation, lip augmentation, reconstructive surgery, orthopedic applications
Primary End Users Dermatologists, Plastic Surgeons, Aesthetic Clinics, Hospitals, Medical Spas, Cosmetic Surgery Centers
Key Growth Drivers Aging population, rising demand for minimally invasive procedures, collagen biostimulation benefits, male aesthetics trend, technological innovation, medical tourism
Measurable Values USD Millions/Units/Volume
Market Segmentation By Type of Product, By End-Use Application, By Distribution Channel, By Region
Top Key Players Merz Aesthetics, AbbVie, CGBio, Luminera, MatexLab (Neauvia), Dr. Korman Laboratories, Shanghai Moyom Biotech, Dermax Medical,Medyglobal, Scientech

Segmental Insights

Calcium Hydroxylapatite Fillers Market Segmentation

By Type of Product Insights

Segment Share 2025 (%)
Injectable Fillers 75%
Non-injectable Fillers 25%

The Injectable Fillers Segment Dominated the Market With 75% in 2025

The injectable fillers segment led the calcium hydroxylapatite fillers market with 75% share in 2025, due to their minimally invasive approach. Their quicker recovery times and more natural results also increased their adoption rates. Additionally, their immediate results and versatile applications also increased their use.

The calcium hydroxylapatite-based fillers sub-segment held 15% of the market share in 2025 and is expected to witness the fastest growth with a CAGR of 9.10% during the forecast period, due to their biostimulatory effect and enhanced restoration volume. They also offer long-lasting results and high structural support, increasing their use. Moreover, growing demand for non-surgical aesthetics and expanding applications are also increasing their use.

The non-injectable fillers segment held 25% of the calcium hydroxylapatite fillers market share in 2025, driven by implants, which offer a permanent solution for those seeking long-term results. Their non-invasive approach and growing beauty awareness are also increasing their use. Growing combinations with other skincare solutions are also increasing their use for at-home applications.

By End-Use Application Insights

Segment Share 2025 (%)
Aesthetic Fillers 80%
Orthopedic Fillers 20%

The Aesthetic Fillers Segment Dominated the Market With 80% in 2025

The aesthetic fillers segment accounted for the highest revenue share of 80% of the calcium hydroxylapatite fillers market in 2025, due to a rise in aesthetic enhancements such as wrinkle reduction. The growth in facial rejuvenation and volume restoration also increased their adoption rates. High beauty consciousness and growth in the demand for non-surgical alternatives also increased their use.

The lip augmentation sub-segment held 30% of market share in 2025 and is expected to show the highest growth with a CAGR of 9.30% during the forecast period, due to growing preference for lip volumization procedures. Growing cosmetic awareness and K-beauty trends are also increasing their use. Moreover, their immediate results and recovery are also increasing their acceptance rates.

The orthopedic fillers segment held 20% of the calcium hydroxylapatite fillers market share in 2025, due to the growing aging population and sports injuries driving the demand for joint treatments. Their collagen and tissue stimulation, along with faster recovery time, are also increasing their adoption rates. Expanding regenerative medicine applications are also increasing their use.

By Distribution Channel Insights

Segment Share 2025 (%)
Hospitals & Clinics 60%
Beauty Salons 20%
Online Sales 20%

The Hospitals & Clinics Segment Dominated the Market With 60% in 2025

The hospitals & clinics segment held a major revenue share of 60% of the calcium hydroxylapatite fillers market in 2025, driven by the presence of a broad range of services. The presence of trained professionals and advanced equipment also increased their preference for patients seeking professional treatments. Moreover, their regulatory compliance also increased their use for reconstructive applications.

The online sales segment held 20% of the market share in 2025 and is expected to expand rapidly with a CAGR of 10.0% during the forecast period, due to the rise of e-commerce and at-home solutions. They also offer enhanced convenience and accessibility, driving the purchase of calcium hydroxylapatite fillers anytime and anywhere. Furthermore, their home deliveries and presence of discounts are also attracting the patients.

The beauty salons segment held 20% of the calcium hydroxylapatite fillers market share in 2025, due to growing demand for non-invasive beauty treatments. The growing demand for non-surgical aesthetic treatments and rising beauty awareness are also increasing their use. Expanding medspa-style salons are also increasing their accessibility for various beauty services, driving the use of calcium hydroxylapatite fillers.

Regional Insights

Calcium Hydroxylapatite Fillers Market Shares for North America, Europe, Asia Pacific, Latin America and Middle East and Africa, 2025 (%).

High Aesthetic Procedures Drive North America Share by 35%

Calcium Hydroxylapatite Fillers Market Size is USD 0.54 Billion in 2026.

North America dominated the calcium hydroxylapatite fillers market with 35% in 2025, due to high demand for aesthetic procedures and the presence of advanced healthcare infrastructure. High disposable income and growth in anti-aging awareness treatments also increased the use of calcium hydroxylapatite fillers. Expanding technological advancements also increased their innovations, which contributed to the market growth.

U.S. Market Trends

The high demand for facial procedures in the U.S. drives the use of calcium hydroxylapatite fillers. The presence of advanced healthcare and regulatory frameworks is also increasing their adoption rates. Growing disposable income and advanced technologies are also increasing their use and innovations.

Canada Calcium Hydroxylapatite Fillers Gain Momentum Through Advanced Aesthetic Innovation

The Canada calcium hydroxylapatite fillers market is experiencing significant growth to the rising demand for minimally invasive cosmetic procedures and long-lasting facial rejuvenation treatments. Increasing awareness of collagen-stimulating injectables, growing disposable incomes, and expanding medical aesthetic clinics are driving adoption. Continuous advancements in filler formulation, precision injection techniques, and personalized aesthetic treatment, along with the growing influence of social media and beauty-conscious consumers, are further accelerating market expansion.

Rising Disposable Incomes Boost Asia Pacific

Asia Pacific held 20% share of the calcium hydroxylapatite fillers market in 2025 and is expected to grow at the fastest CAGR of 9.0% during the forecast period, driven by rising disposable incomes and a growing interest in cosmetic procedures. Growing beauty awareness and expanding healthcare infrastructure are also increasing the adoption of calcium hydroxylapatite fillers. Expanding medical tourism and non-surgical cosmetic procedures are also enhancing the market growth.

China Market Trends

The growth in aesthetic demand from urban areas with high income levels across China is increasing the adoption of calcium hydroxylapatite fillers. Strong beauty consciousness and expanding medical aesthetics industries are also increasing their use. Additionally, growing demand for non-surgical cosmetic procedures and growing innovations are also propelling their rapid adoption.

India Emerges as a High-Growth Market for Calcium Hydroxylapatitie Fillers

India Emerges as a High-Growth Market for Calcium Hydroxylapatite fillers market due to increasing demand for minimally invasive aesthetic procedures, rising disposable incomes, and growing awareness of facial rejuvenation treatments. The expansion of dermatology and cosmetic clinics, increasing medical tourism, and greater availability of advanced injectable fillers are driving adoption. Rising preference for collagen-stimulating treatments and continuous advancements in aesthetic technologies are further supporting market growth.

Europe Driven by Non-Surgical Aesthetic Treatments

Europe is expected to grow significantly in the calcium hydroxylapatite fillers market, with a share of 30% during the forecast period, due to growing preference for non-surgical aesthetic treatments. Rising geriatric population, awareness of minimally invasive treatments, and the male aesthetics segment are also increasing the use of calcium hydroxylapatite fillers. Stringent regulatory frameworks and advanced healthcare systems are also increasing their adoption, promoting the market growth.

UK Market Trends

The growing demand for facial rejuvenation procedures is increasing the use of calcium hydroxylapatite fillers across the UK. Growing awareness regarding facial aesthetics and minimally invasive procedures is also increasing their use. Expanding male grooming trends and high disposable income are also increasing their adoption rates.

High Demand for Aesthetic Treatments Propels Middle East & Africa

The Middle East & Africa are expected to grow notably with 8% share of the calcium hydroxylapatite fillers market during the forecast period, due to growing demand for aesthetic treatments. Growing disposable income and increasing interest in anti-aging treatments are also increasing the use of calcium hydroxylapatite fillers. Expanding cosmetic clinics and social media influence are also increasing their use, propelling the market growth.

Saudia Arabia Market Trends

Increasing demand for non-invasive beauty procedures is Saudia Arabia is increasing the use of calcium hydroxylapatite fillers. Growing demand for minimally invasive procedures, high disposable income, and increasing government support are also increasing their adoption rates. Expanding medical tourism and medspa networks are also increasing their use.

Market Ecosystem Analysis

Ecosystem Segment Key Participants Role in Market
Technology Providers Merz Aesthetics, AbbVie, CGBio Develop filler formulations, delivery systems, and biostimulatory technologies
Product Manufacturers Merz Aesthetics, AbbVie, CGBio, Luminera, Neauvia Manufacture and commercialize CaHA fillers
Service Providers Dermatology Clinics, Plastic Surgery Centers, Medical Spas Administer filler procedures and patient care
Platform Providers Merz Aesthetics, AbbVie Allergan Aesthetics Training platforms, injector education, patient engagement programs
CROs/CDMOs ICON plc, Charles River Laboratories, WuXi AppTec Clinical development, regulatory support, manufacturing services
Software Vendors Canfield Scientific, Vectra (Canfield), Crisalix AI facial imaging, treatment planning, aesthetic visualization
Research Institutions Mayo Clinic, Harvard Medical School, Stanford University Clinical research and regenerative medicine studies
End-User Industries Medical Aesthetics, Cosmetic Surgery, Dermatology, Regenerative Medicine Commercial adoption and treatment delivery

Latest announcement by Industry Leaders

In March 2025, “It answers a growing demand amongst consumers for skin quality and skin regeneration. It is very complementary to our existing STYLAGE® Hyaluronic Acid (HA) portfolio where we have a clear leadership in Europe. We will deploy NOVUMA in the coming months across Europe first and expand to other geographies with one objective in mind: offer our physician partners the best technologies to meet patients’ expectations for safe, effective solutions that improve their appearance and the quality of their skin”, said Bertrand Frohly, President & CEO at Laboratoires VIVACY.

Calcium Hydroxylapatite Fillers Market Value Chain Analysis

R&D

  • The R&D of the calcium hydroxylapatite fillers focuses on the development of hybrid biostimulants by combining calcium hydroxylapatite fillers with hyaluronic acid.
  • Key players: Merz Aesthetics, Allergan (AbbVie).

Clinical Trials and Regulatory Approvals

  • The safety, long-term efficacy, and biocompatibility are evaluated in the clinical trials and regulatory approvals of the calcium hydroxylapatite fillers.
  • Key players: Merz Aesthetics, Allergan (AbbVie).

Formulation and Final Dosage Preparation

  • The formulation and final dosage preparation of the calcium hydroxylapatite fillers involves the development of injectable mucoadhesive gels consisting of calcium hydroxyapatite microspheres suspended in carboxymethylcellulose or hyaluronic acid carriers, which are incorporated in pre-filled sterile syringes.
  • Key players: Merz Aesthetics, CGBio.

Packaging and Serialization

  • The packaging and serialization of calcium hydroxylapatite fillers involves the use of sterile, pre-filled syringes, blister packs, tamper-evident cartons, and unique 2D data matrix codes.
  • Key players: Merz Aesthetics, Allergan (AbbVie).

Distribution to Hospitals, Pharmacies

  • The specialised cold-chain logistics and authorised medical distributors are responsible for the distribution of the calcium hydroxylapatite fillers to the hospitals and pharmacies.
  • Key players: Merz Aesthetics, Allergan (AbbVie).

Patient Support and Services

  • The post-treatment care apps, educational portals, and loyalty reward programmes are provided in the patient support and services of the calcium hydroxylapatite fillers.
  • Key players: Merz Aesthetics, Allergan (AbbVie).

Who are the Calcium Hydroxylapatite Fillers Market Top Vendors and What are Their Offerings?

Calcium Hydroxylapatite Fillers Market Companies are Merz Aesthetics, AbbVie, CGBio, Luminera, MatexLab (Neauvia), Dr. Korman Laboratories, Shanghai Moyom Biotech, Dermax Medical,Medyglobal, Scientech

Market Share Influence Assessment

  Tier 1 Tier 2 Tier 3
Typical Market Influence 72% 20% 8%

Competitive Landscape

Tier 1
Company Name Headquarters Country Why Relevant to This Market Key Products/Services
Merz Aesthetics Raleigh, North Carolina United States Global leader and owner of the most recognized CaHA filler franchise Radiesse®, Radiesse(+)
AbbVie (Allergan Aesthetics) Irvine, California United States Major aesthetics company with extensive filler portfolio and global distribution HArmonyCa™, Juvederm portfolio
CGBio Co., Ltd. Seoul South Korea Strong biostimulatory filler developer with expanding international presence FACETEM
Tier 2
Company Name Headquarters Country Why Relevant to This Market Key Products/Services
Luminera Derm Ltd. Lod Israel Established dermal filler manufacturer with CaHA portfolio Crystalys
BioPlus Co., Ltd. Seoul South Korea Growing aesthetic filler producer with international expansion BONTA-related aesthetic solutions and filler portfolio
Dr. Korman Laboratories Ltd. Kiryat Motzkin Israel Specialized CaHA filler developer Hydroxyfill
Tier 3
Company Name Headquarters Country Why Relevant to This Market Key Products/Services
Shanghai Moyom Biotech Co., Ltd. Shanghai China Emerging Chinese CaHA filler manufacturer Magic Crystal / Aphranel series
Dermax Medical Technology Hebei Province China Specialized dermal filler manufacturer with international exports CHArmacy CaHA fillers
Medyglobal Madrid Spain Focused aesthetics company developing CaHA-based products CaHA Express

SWOT Analysis

Strengths

  • The calcium hydroxylapatite fillers help in stimulating natural collagen products, which increases their adoption rates.
  • Their natural, immediate, and long-lasting results also drive their acceptance rates.
  • Their enhanced safety, biocompatibility, and low migration rates also increase their use.
  • Their high structural support and enhanced elasticity also promote their use.

Weaknesses

  • Irreversibility, risk of misplacements, and limited superficial areas applications are some of the major weaknesses in the calcium hydroxylapatite fillers market, which limit their adoption rates.
  • Risk of swelling, bruising, and formation of nodules also limits their use.

Opportunities

  • Growing aging awareness is driving the demand for calcium hydroxylapatite fillers.
  • Expanding demand for long-lasting fillers and demand for non-surgical aesthetics are also increasing their use.
  • Similarly, growing male aesthetics and demand for regenerative medicine are also increasing their adoption rates.
  • Growing combination therapies and technological advancements are also driving the development of new treatment options.

Threats

  • Contamination risk and the requirement of expensive raw materials and techniques restrict the calcium hydroxylapatite filler innovations.
  • Compliance with stringent regulatory standards and quality control also slows down their production, where their failure leads to product rejection or recalls.

What are the Recent Developments in the Calcium Hydroxylapatite Fillers Market?

  • In March 2026, BELOTERO® Balance, a versatile hyaluronic acid dermal filler designed to integrate seamlessly within the skin and offer harmonious aesthetic outcomes, developed by Merz Aesthetics®, was announced to have received EU approval for additional indications, that is, the treatment of horizontal forehead lines and infraorbital hollows.
  • In September 2025, MagIQ™, an injectable hyaluronic acid (HA) gel, was announced to have received U.S. FDA approval, making it the first product in the Obagi® saypha® collection under the Obagi Medical brand, expanding Obagi Medical’s aesthetics portfolio, and introducing Waldencast plc into the U.S. HA dermal filler market.
  • In September 2025, to offer clear, factual education about HA injectable fillers, tackle the misinformation, and guide about safe, natural-looking outcomes of hyaluronic acid injectable fillers, the "Naturally You with Injectable Hyaluronic Acid Fillers" campaign was launched by Allergan Aesthetics, an AbbVie company.

Segments Covered in the Report

By Type of Product

  • Injectable Fillers
    • Hyaluronic Acid-based Fillers
    • Calcium Hydroxylapatite-based Fillers
  • Non-injectable Fillers
    • Implants

By End-Use Application

  • Aesthetic Fillers
    • Facial Wrinkles & Folds
    • Lip Augmentation
    • Chin Augmentation
  • Orthopedic Fillers
    • Joint Reconstruction
    • Bone Grafting

By Distribution Channel

  • Hospitals & Clinics
    • Private Clinics
    • Public Hospitals
  • Beauty Salons
  • Online Sales

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
    • Rest of North America
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Europe
    • Western Europe
      • Germany
      • Italy
      • France
      • Netherlands
      • Spain
      • Portugal
      • Belgium
      • Ireland
      • UK
      • Iceland
      • Switzerland
      • Poland
      • Rest of Western Europe
    • Eastern Europe
      • Austria
      • Russia & Belarus
      • Türkiye
      • Albania
      • Rest of Eastern Europe
  • Asia Pacific
    • China
    • Taiwan
    • India
    • Japan
    • Australia and New Zealand
    • ASEAN Countries (Singapore, Malaysia)
    • South Korea
    • Rest of APAC
  • MEA
    • GCC Countries
      • Saudi Arabia
      • United Arab Emirates (UAE)
      • Qatar
      • Kuwait
      • Oman
      • Bahrain
    • South Africa
    • Egypt
    • Rest of MEA

FAQ's

Finding : The calcium hydroxylapatite fillers market stands at USD 1.8 billion in 2026 and is expected to reach USD 3.55 billion by 2035, growing at a CAGR of 7.82% from 2026 to 2035.

Finding : North America is currently leading the calcium hydroxylapatite fillers market by 35% due to high demand for aesthetic procedures.

Finding : Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.

Tags

Meet the Team

Payal Rabde

Payal Rabde

Principal Consultant

Payal Rabde is a Healthcare Market Research Analyst at Towards Healthcare Research & Consulting with 4+ years of experience in pharmaceuticals, biotechnology, medical devices, and life sciences.

Learn more about Payal Rabde
Aditi Shivarkar

Aditi Shivarkar LinkedIn

Reviewed By

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar
Calcium Hydroxylapatite Fillers Market
Updated Date: 20 July 2026   |   Report Code: 6826